These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 33085891)

  • 1. Identification of Noncompetitive Protein-Ligand Interactions for Structural Optimization.
    Tosstorff A; Cole JC; Taylor R; Harris SF; Kuhn B
    J Chem Inf Model; 2020 Dec; 60(12):6595-6611. PubMed ID: 33085891
    [TBL] [Abstract][Full Text] [Related]  

  • 2. How Significant Are Unusual Protein-Ligand Interactions? Insights from Database Mining.
    Kuhn B; Gilberg E; Taylor R; Cole J; Korb O
    J Med Chem; 2019 Nov; 62(22):10441-10455. PubMed ID: 31730345
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Template-Based Method for Conformation Generation and Scoring for Congeneric Series of Ligands.
    Raman EP
    J Chem Inf Model; 2019 Jun; 59(6):2690-2701. PubMed ID: 31045363
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chiral Graphs: Reduced Representations of Ligand Scaffolds for Stereoselective Biomolecular Recognition, Drug Design, and Enhanced Exploration of Chemical Structure Space.
    Mikhael S; Abrol R
    ChemMedChem; 2019 Apr; 14(8):798-809. PubMed ID: 30821046
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Rationalizing tight ligand binding through cooperative interaction networks.
    Kuhn B; Fuchs JE; Reutlinger M; Stahl M; Taylor NR
    J Chem Inf Model; 2011 Dec; 51(12):3180-98. PubMed ID: 22087588
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hydration properties of ligands and drugs in protein binding sites: tightly-bound, bridging water molecules and their effects and consequences on molecular design strategies.
    García-Sosa AT
    J Chem Inf Model; 2013 Jun; 53(6):1388-405. PubMed ID: 23662606
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Distilling the essential features of a protein surface for improving protein-ligand docking, scoring, and virtual screening.
    Zavodszky MI; Sanschagrin PC; Korde RS; Kuhn LA
    J Comput Aided Mol Des; 2002 Dec; 16(12):883-902. PubMed ID: 12825621
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Structural analysis of protein-ligand interactions: the binding of endogenous compounds and of synthetic drugs.
    Gallina AM; Bork P; Bordo D
    J Mol Recognit; 2014 Feb; 27(2):65-72. PubMed ID: 24436123
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Computational method to identify druggable binding sites that target protein-protein interactions.
    Li H; Kasam V; Tautermann CS; Seeliger D; Vaidehi N
    J Chem Inf Model; 2014 May; 54(5):1391-400. PubMed ID: 24762202
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comprehensive classification and diversity assessment of atomic contacts in protein-small ligand interactions.
    Kasahara K; Shirota M; Kinoshita K
    J Chem Inf Model; 2013 Jan; 53(1):241-8. PubMed ID: 23186137
    [TBL] [Abstract][Full Text] [Related]  

  • 11. nAPOLI: A Graph-Based Strategy to Detect and Visualize Conserved Protein-Ligand Interactions in Large-Scale.
    Fassio AV; Santos LH; Silveira SA; Ferreira RS; de Melo-Minardi RC
    IEEE/ACM Trans Comput Biol Bioinform; 2020; 17(4):1317-1328. PubMed ID: 30629512
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Computational analysis of BACE1-ligand complex crystal structures and linear discriminant analysis for identification of BACE1 inhibitors with anti P-glycoprotein binding property.
    Manoharan P; Chennoju K; Ghoshal N
    J Biomol Struct Dyn; 2018 Jan; 36(1):262-276. PubMed ID: 28081663
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Structural parameterization of the binding enthalpy of small ligands.
    Luque I; Freire E
    Proteins; 2002 Nov; 49(2):181-90. PubMed ID: 12210999
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Halogens in Protein-Ligand Binding Mechanism: A Structural Perspective.
    Shinada NK; de Brevern AG; Schmidtke P
    J Med Chem; 2019 Nov; 62(21):9341-9356. PubMed ID: 31117513
    [TBL] [Abstract][Full Text] [Related]  

  • 15. GPCR drug discovery through the exploitation of allosteric drug binding sites.
    Rees S; Morrow D; Kenakin T
    Recept Channels; 2002; 8(5-6):261-8. PubMed ID: 12690954
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A searchable database for comparing protein-ligand binding sites for the analysis of structure-function relationships.
    Gold ND; Jackson RM
    J Chem Inf Model; 2006; 46(2):736-42. PubMed ID: 16563004
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Relative Binding Free Energy Calculations Applied to Protein Homology Models.
    Cappel D; Hall ML; Lenselink EB; Beuming T; Qi J; Bradner J; Sherman W
    J Chem Inf Model; 2016 Dec; 56(12):2388-2400. PubMed ID: 28024402
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Estimation of the protein-ligand interaction energy for model building and validation.
    Beshnova DA; Pereira J; Lamzin VS
    Acta Crystallogr D Struct Biol; 2017 Mar; 73(Pt 3):195-202. PubMed ID: 28291754
    [TBL] [Abstract][Full Text] [Related]  

  • 19. AutoSite: an automated approach for pseudo-ligands prediction-from ligand-binding sites identification to predicting key ligand atoms.
    Ravindranath PA; Sanner MF
    Bioinformatics; 2016 Oct; 32(20):3142-3149. PubMed ID: 27354702
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nonlinear scoring functions for similarity-based ligand docking and binding affinity prediction.
    Brylinski M
    J Chem Inf Model; 2013 Nov; 53(11):3097-112. PubMed ID: 24171431
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.